We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.68B
AUM Growth
-$270M
(-5.5%)
Cap. Flow
-$364M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
11.36%
Holding
1,103
New
193
Increased
369
Reduced
317
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$25.2M |
| 2 |
Ashland
ASH
|
+$17.2M |
| 3 |
IBM
IBM
|
+$17.1M |
| 4 |
Madison Square Garden
MSGS
|
+$16.7M |
| 5 |
Valero Energy
VLO
|
+$16.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$35.9M |
| 2 |
Qualcomm
QCOM
|
+$29M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$27.5M |
| 4 |
Agilent Technologies
A
|
+$26.4M |
| 5 |
Northrop Grumman
NOC
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 19.14% |
| 3 | Healthcare | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PBPB
476
DELISTED
Potbelly
PBPB
| $1.64M | 0.04% |
142,200
+140
| +0.1% | +$1.71K |
|
477
Werner Enterprises
WERN
$2.54B
| $1.64M | 0.04% |
+55,690
| New | +$1.52M |
|
|
NEWR
478
DELISTED
New Relic, Inc.
NEWR
| $1.63M | 0.03% |
+38,000
| New | +$1.58M |
|
479
JB Hunt Transport Services
JBHT
$27.1B
| $1.63M | 0.03% |
+17,870
| New | +$1.58M |
|
480
Estee Lauder
EL
$29B
| $1.63M | 0.03% |
17,000
-55,700
| -77% | -$5.11M |
|
481
Kennametal
KMT
$2.68B
| $1.63M | 0.03% |
43,550
+1,820
| +4% | +$71.2K |
|
482
Berkshire Hathaway Class B
BRK.B
$1.07T
| $1.62M | 0.03% |
9,582
-1,420
| -13% | -$236K |
|
|
SHOE
483
Shoe Station Group
SHOE
$395M
| $1.62M | 0.03% |
+155,068
| New | +$1.71M |
|
484
Coca-Cola Consolidated
COKE
$12.3B
| $1.61M | 0.03% |
70,500
+37,800
| +116% | +$816K |
|
485
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
| $1.61M | 0.03% |
5,080
| – | – |
|
|
AXE
486
DELISTED
Anixter International Inc
AXE
| $1.61M | 0.03% |
20,590
+1,180
| +6% | +$92.2K |
|
487
Goldman Sachs
GS
$313B
| $1.6M | 0.03% |
7,200
-15,770
| -69% | -$3.5M |
|
|
CTRL
488
DELISTED
Control4 Corporation
CTRL
| $1.6M | 0.03% |
81,470
+7,360
| +10% | +$132K |
|
489
SLB Ltd
SLB
$78.4B
| $1.6M | 0.03% |
+24,250
| New | +$1.74M |
|
490
Yelp
YELP
$1.38B
| $1.58M | 0.03% |
52,510
+7,630
| +17% | +$238K |
|
|
SPTN
491
DELISTED
SpartanNash
SPTN
| $1.57M | 0.03% |
60,328
-5,370
| -8% | -$177K |
|
492
Calix
CALX
$2.3B
| $1.55M | 0.03% |
226,927
-22,800
| -9% | -$155K |
|
493
Take-Two Interactive
TTWO
$43B
| $1.55M | 0.03% |
+21,110
| New | +$1.45M |
|
|
UFS
494
DELISTED
DOMTAR CORPORATION (New)
UFS
| $1.54M | 0.03% |
40,140
-350
| -0.9% | -$13.1K |
|
495
Citi Trends
CTRN
$524M
| $1.52M | 0.03% |
71,720
+36,930
| +106% | +$697K |
|
496
Fortive
FTV
$19B
| $1.51M | 0.03% |
+37,789
| New | +$1.49M |
|
497
Harmonic Inc
HLIT
$1.21B
| $1.5M | 0.03% |
284,800
-176,832
| -38% | -$951K |
|
498
Xerox
XRX
$337M
| $1.49M | 0.03% |
51,774
-633,902
| -92% | -$17.9M |
|
499
Veeco
VECO
$3.15B
| $1.48M | 0.03% |
53,056
-10,160
| -16% | -$312K |
|
500
Interparfums
IPAR
$3.92B
| $1.48M | 0.03% |
+40,309
| New | +$1.45M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2017 Portfolio in Review
As of Q2 2017, Jacobs Levy Equity Management held 1,103 positions worth $4.68B, down 5.5% from $4.95B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management withdrew a net $364M in Q2 2017, closing 187 positions and reducing 317 holdings. Its most notable exit was CVS Health, an estimated $35.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Humana worth $26.8M.
- Jacobs Levy Equity Management's largest Q2 2017 buy was Humana: 111,320 shares worth $26.8M.
- Jacobs Levy Equity Management added most to Madison Square Garden in Q2 2017, an estimated $16.7M increase.
- Jacobs Levy Equity Management's biggest Q2 2017 reduction was Agilent Technologies, cutting an estimated $26.4M.
- Jacobs Levy Equity Management fully exited CVS Health in Q2 2017, selling an estimated $35.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $4.68B portfolio in Q2 2017.
- Jacobs Levy Equity Management opened 193 new positions and closed 187 in Q2 2017.
- Jacobs Levy Equity Management's portfolio value fell 5.5% quarter-over-quarter to $4.68B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2017, filed 14 Aug 2017.